Cyclohexane

Cyclohexane

SCHEMBL8027519

C1CCCCC1.CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.76
▸ LMNA P02545 3/20 0.76
▸ SERPINA6 P08185 2/20 0.62
▸ ALDH1A1 P00352 2/20 0.62
▸ THRB P10828 2/20 0.62
▸ SLC22A1 O15245 1/20 0.62
▸ SHBG P04278 1/20 0.62
▸ CYP3A4 P08684 3/20 0.61
▸ PGR P06401 2/20 0.61
▸ NR1I2 O75469 1/20 0.61
▸ NR3C1 P04150 1/20 0.61
▸ CYP17A1 P05093 1/20 0.61
▸ AR P10275 1/20 0.61
▸ CYP2C9 P11712 1/20 0.61
▸ TSHR P16473 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ OPRK1 P41145 1/20 0.61
▸ MCL1 Q07820 1/20 0.59
▸ CYP1A2 P05177 1/20 0.59
▸ HIF1A Q16665 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL343128 0.98 MAPT (0.79) MAPTLMNASERPINA6ALDH1A1THRB
SCHEMBL21067996 0.91 MAPT (0.84) MAPTLMNASERPINA6ALDH1A1THRB
SCHEMBL11121455 0.89 MAPT (0.75) MAPTLMNASERPINA6ALDH1A1THRB
SCHEMBL604525 0.88 LMNA (0.73) MAPTLMNASERPINA6ALDH1A1THRB
SCHEMBL17419490 0.87 MAPT (0.98) MAPTLMNASERPINA6ALDH1A1THRB
SCHEMBL23752494 0.87 MAPT (0.78) MAPTLMNASERPINA6ALDH1A1THRB
SCHEMBL17419472 0.87 MAPT (0.78) MAPTLMNASERPINA6ALDH1A1THRB
SCHEMBL14568852 0.87 MAPT (1.00) MAPTLMNASERPINA6ALDH1A1THRB
SCHEMBL11593159 0.87 MAPT (1.00) MAPTLMNASERPINA6ALDH1A1THRB
SCHEMBL11351978 0.87 MAPT (1.00) MAPTLMNASERPINA6ALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811547-A Method for inducing crystalline state transition in medicinal substance NIPPON SHINYAJU CO., LTD. (JP) 1998-09-22 — — US claimed
EP-0665009-B1 CRYSTALLINE CONDITION DISLOCATING METHOD NIPPON SHINYAKU CO LTD (JP) 2000-02-16 — — EP disclosed
US-5811547-A Method for inducing crystalline state transition in medicinal substance NIPPON SHINYAJU CO., LTD. (JP) 1998-09-22 — — US disclosed
EP-0665009-A1 CRYSTALLINE CONDITION DISLOCATING METHOD NIPPON SHINYAKU COMPANY, LIMITED (JP) 1995-08-02 — — EP disclosed
Send feedback